{"analyses":[{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.23","pValueComment":"One-sided significance level 0.05","statisticalMethod":"t-test, 1 sided"},{"groupIds":["OG001","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.25","pValueComment":"One-sided significance level 0.05","statisticalMethod":"t-test, 1 sided"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"40"}]}],"title":"No"},{"categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"21"}]}],"title":"Yes"}],"denoms":[{"counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"61"}],"units":"Participants"}],"description":"Participants are asked, \"Were the benefits of this treatment greater than any side effects?\"","groups":[{"description":"One Bupropion 150 mg XL capsule PO in a.m. daily for one week; one Bupropion 150 mg XL capsule and one placebo capsule PO in a.m. daily for 8 weeks; one placebo capsule daily PO in a.m. for one 1 week (titration off).","id":"OG000","title":"Bupropion 150 mg"},{"description":"One Bupropion 150 mg XL capsule PO in a.m. daily for one week; two Bupropion 150 mg XL capsules PO in a.m. daily for 8 weeks (300 mg target dose); one Bupropion 150 mg XL capsule PO in a.m. daily for 1 week (titration off)","id":"OG001","title":"Bupropion 300 mg"},{"description":"One placebo capsule PO in a.m. daily for 1 week; two placebo capsules PO in a.m. daily for 8 weeks; one placebo capsule PO in a.m. daily for 1 week (titration off)","id":"OG002","title":"Placebo"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Eligible with data","reportingStatus":"POSTED","timeFrame":"9 weeks from start of study treatment (within 21 days of randomization)","title":"Perception of Risk vs. Benefit at 9 Weeks","type":"SECONDARY","unitOfMeasure":"Participants"}